(Q35142828)

6 August 2017

1 reference

title

Molecular targets in therapy for human soft-tissue and bone sarcomas (English)

1 reference

6 August 2017

Dejka M Steinert

1

1 reference

6 August 2017

L Johnetta Blakely

series ordinal

2

1 reference

6 August 2017

Jason Salganick

series ordinal

3

1 reference

6 August 2017

Jonathan C Trent

series ordinal

4

1 reference

6 August 2017

publication date

1 July 2003

1 reference

6 August 2017

published in

Current Oncology Reports

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

295-303

1 reference

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0069-8

Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0069-8

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0069-8

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-003-0069-8

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

21 January 2018

1 reference

12 December 2020

Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies

1 reference

12 December 2020

Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract.

1 reference

12 December 2020

Cell signaling by receptor tyrosine kinases

1 reference

12 December 2020

Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin

1 reference

12 December 2020

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

12 December 2020

Platelet derived growth factor/tyrosine kinase receptor mediated proliferation

1 reference

12 December 2020

Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I

1 reference

12 December 2020

Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.

1 reference

12 December 2020

Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis

1 reference

12 December 2020

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

12 December 2020

Phase I and pharmacokinetic trial of weekly CPT-11

1 reference

12 December 2020

Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB.

1 reference

12 December 2020

An activity from mammalian cells that untwists superhelical DNA--a possible swivel for DNA replication (polyoma-ethidium bromide-mouse-embryo cells-dye binding assay).

1 reference

12 December 2020

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Cancer statistics, 2002

1 reference

12 December 2020

Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms

1 reference

12 December 2020

Caspases: enemies within

1 reference

12 December 2020

Inflammatory myofibroblastic tumor in children

1 reference

12 December 2020

Apoptosis, bcl-2 expression, and p53 expression in gastrointestinal stromal/smooth muscle tumors.

1 reference

12 December 2020

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

12 December 2020

Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors

1 reference

12 December 2020

Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors

1 reference

12 December 2020

Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation

1 reference

12 December 2020

Mitochondria-dependent apoptosis and cellular pH regulation

1 reference

12 December 2020

Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations.

1 reference

12 December 2020

Clonal changes in inflammatory pseudotumor of the lung: a case report

1 reference

12 December 2020

Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression.

1 reference

12 December 2020

Differential migratory response of U-2 OS osteosarcoma cell to the various forms of platelet-derived growth factor

1 reference

12 December 2020

Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

1 reference

12 December 2020

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

1 reference

12 December 2020

The PDGF-inducible 'competence genes': intracellular mediators of the mitogenic response

1 reference

12 December 2020

Different effects of homo- and heterodimers of platelet-derived growth factor A and B chains on human and mouse fibroblasts

1 reference

12 December 2020

Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance.

1 reference

12 December 2020

Bcl-2 initiates a new category of oncogenes: regulators of cell death

1 reference

12 December 2020

Topoisomerase I inhibitors: review and update

1 reference

12 December 2020

Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptors

1 reference

12 December 2020

Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience

1 reference

12 December 2020

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

12 December 2020

Mechanisms of apoptosis avoidance in cancer.

1 reference

12 December 2020

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients

1 reference

12 December 2020

Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides.

1 reference

12 December 2020

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

12 December 2020

Mutator phenotype may be required for multistage carcinogenesis

1 reference

12 December 2020

Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: Implications for autocrine receptor activation

1 reference

12 December 2020

A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences

1 reference

12 December 2020

Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas

1 reference

12 December 2020

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma

1 reference

12 December 2020

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

12 December 2020

Detection of Epstein-Barr Virus in inflammatory pseudotumor

1 reference

12 December 2020

A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy

1 reference

12 December 2020

Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.

1 reference

12 December 2020

Molecular pathology of soft tissue and bone tumors. A review

1 reference

12 December 2020

Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.

1 reference

12 December 2020

Transformation of NIH 3T3 cells by a human c-sis cDNA clone

1 reference

12 December 2020

ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma

1 reference

12 December 2020

Mechanism of action and in vivo role of platelet-derived growth factor

1 reference

12 December 2020

Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin.

1 reference

12 December 2020

Human herpesvirus-8 genes are expressed in pulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor).

1 reference

12 December 2020

Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.

1 reference

12 December 2020

Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.

1 reference

12 December 2020

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.

1 reference

12 December 2020

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas

1 reference

12 December 2020

Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 Cases

1 reference

12 December 2020

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

12 December 2020

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children

1 reference

12 December 2020

Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study

1 reference

12 December 2020

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients

1 reference

12 December 2020

Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma

1 reference

12 December 2020

Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice

1 reference

12 December 2020

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

1 reference

12 December 2020

10.1007/S11912-003-0069-8

Identifiers

DOI

1 reference

6 August 2017

1 reference